Banco Bilbao Vizcaya Argentaria S.A. Common Stock (BBVA)

Long-Term Debt

€106.16B

Quarterly · Period ending: · EUR

BBVA logo

BBVA Long-Term Debt

Latest reported€106.16B EUR
BBVA Quarterly Long-Term Debt · EUR (€16.53B → €106.16B)
High-resolution chart · PNG

BBVA long-term debt history

Quarterly · EUR. Dates are reporting period ends; fiscal years can differ from calendar years.

Banco Bilbao Vizcaya Argentaria S.A. Common Stock Long-Term Debt — Quarterly (EUR)
Period endingLong-Term Debt (EUR)
106,155,000,000
87,564,000,000
81,842,000,000
84,097,000,000
71,802,000,000
73,437,000,000
75,755,000,000
67,325,000,000
74,972,000,000
73,627,000,000
74,192,000,000
70,425,000,000
68,207,000,000
57,853,000,000
60,116,000,000
59,238,000,000
58,982,000,000
59,227,000,000
61,719,000,000
58,992,000,000
58,789,000,000
61,395,000,000
68,985,000,000
67,024,000,000
71,752,000,000
64,937,000,000
71,953,000,000
63,324,000,000
70,495,000,000
69,409,000,000
63,972,000,000
62,022,000,000
65,044,000,000
60,866,000,000
63,916,000,000
69,467,000,000
69,702,000,000
72,840,000,000
76,609,000,000
76,597,000,000
75,734,000,000
75,071,000,000
82,268,000,000
82,000,000,000
78,425,000,000
73,982,000,000
72,191,000,000
75,446,000,000
76,466,000,000
75,015,000,000
74,676,000,000
83,528,000,000
90,801,000,000
95,822,000,000
98,070,000,000
98,689,000,000
97,723,000,000
98,490,000,000
96,427,000,000
106,372,000,000
104,259,000,000
106,172,000,000
102,599,000,000
112,947,000,000
105,395,000,000
115,815,000,000
117,817,000,000
0
130,159,000,000
126,251,000,000
121,144,000,000
0
98,663,000,000
100,188,000,000
117,909,000,000
0
100,834,717,300
0
100,079,000,000
0
88,528,129,908
0
76,565,000,000
4,139,000,000
3,589,000,000
3,829,000,000
59,129,785,123
117,530,907,000
120,764,891,520
113,496,852,780
103,171,494,020
102,402,412,350
93,142,518,700
91,631,169,000
90,210,774,209
92,577,377,200
89,890,386,600
96,892,926,900
97,744,335,253
125,251,960,800
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.